What a new national study reveals about mesothelioma, occupational exposure, and the future of workers' compensation claims.
A new peer-reviewed analysis published in JCO Global Oncology on June 11, 2026, offers the most comprehensive look in years at how mesothelioma burden has shifted across the United States. Drawing on Global Burden of Disease data from 1990 to 2023, the authors examined incidence, mortality, disability, and the share of disease tied to workplace asbestos exposure, broken down by sex and across all fifty states. The headline finding is deceptively reassuring: national rates are down. The deeper story is far more complicated and carries direct consequences for the workers' compensation system, which exists to support those who fall ill.
The Numbers Are Falling, But Not Everywhere
Nationally, the age-standardized incidence rate declined roughly 33 percent, and the age-standardized mortality rate fell about 31 percent over the study period. Those declines track the long arc of asbestos regulation that began in the 1970s. United States asbestos consumption collapsed from a peak of about 803,000 metric tons in 1973 to less than 520 tons annually since 2017. Because mesothelioma can take more than 40 years to develop after exposure, the benefits of early controls are only now becoming apparent in the data.
The decline, however, is heavily concentrated among men. Male incidence dropped about 42 percent and male mortality about 41 percent, reflecting the gradual aging out of heavily exposed cohorts in shipbuilding, construction, and insulation work. Female rates barely moved, with incidence down a statistically insignificant 6.5 percent and mortality down about 8 percent.
A Rising Burden Among Women
The most striking trend in the study is the divergence between men and women. Female incidence increased in 20 states, and mortality increased in 18, with the largest gains in South Dakota, Arkansas, Mississippi, and West Virginia. This pattern points away from traditional occupational exposure and toward other pathways: secondhand or take-home exposure from a spouse or parent who worked with asbestos, environmental contamination, and contested questions about asbestos in cosmetic talc products.
The study notes that women exposed through a household member working in an asbestos industry can face up to a tenfold higher risk, and that environmental exposure tends to affect men and women in roughly equal proportions, unlike the four- to eight-fold male predominance seen with direct occupational exposure. For claims professionals, this signals a population of potential claimants whose exposure histories do not fit the classic shipyard or insulation profile.
Survival Has Not Improved
Perhaps the most sobering finding concerns the mortality-to-incidence ratio, a population-level proxy for survival. That ratio rose nationally from 0.93 to 0.95 and climbed among men from 0.95 to 0.98. In plain terms, despite immunotherapy approvals since 2020, there has been no detectable population-level improvement in survival across three decades. Mesothelioma remains among the most lethal solid tumors, with only about 23 percent of patients surviving five years, even when the disease is caught early.
Absolute numbers tell a story that age-standardized rates can obscure. Even as rates fell, the raw count of cases and deaths rose because the population grew older and larger. Disability-adjusted life-years increased 14 percent since 1990. Mesothelioma is declining in relative terms while still imposing a substantial and, in many places, growing human cost.
Where Workers' Compensation Fits In
Although this is an epidemiology paper, workers' compensation runs through its core finding. In 2023, occupational asbestos exposure accounted for 95.7 percent of all United States mesothelioma deaths, a figure essentially unchanged since 1990. This near-universal occupational attribution is the foundation on which compensability rests. When a disease is overwhelmingly caused by workplace exposure, the legal presumption that it is work-related becomes far easier to establish.
That occupational link is also what historically pushed mesothelioma litigation beyond the boundaries of the compensation system. In the seminal case of Borel v. Fibreboard Paper Products Corp., an insulation worker recovered under the Texas Workers' Compensation Act, but his statutory recovery was capped. He then pursued the asbestos manufacturers in tort, establishing the duty-to-warn framework that opened the door to decades of third-party product liability claims. That two-track structure, a capped workers' compensation remedy against the employer alongside a tort remedy against product manufacturers, remains the backbone of asbestos compensation today.
The state-level heterogeneity in the study matters for compensation systems, too. The highest-burden states in 2023 were Maine, Alaska, Washington, and Minnesota, each with a distinct exposure history: shipbuilding in Maine and Washington, taconite iron ore mining in Minnesota, and naturally occurring asbestos in Alaska. State compensation programs, occupational disease registries, and remediation priorities should reflect these place-based realities rather than a single national average.
What This Means for Worker Benefits
For workers occupationally exposed to asbestos, the study reinforces several practical points. The disease remains overwhelmingly preventable and overwhelmingly work-related, which strengthens the evidentiary basis for compensability and for occupational-disease presumptions. The long latency means that new claims will continue to surface for decades, well after the worker has retired or changed industries, underscoring the importance of statutes of limitations that run from diagnosis rather than from last exposure.
The persistently high mortality-to-incidence ratio carries a sober implication for benefits: because survival remains poor, many claims will proceed as dependency or death claims rather than as long-term disability claims. That reality places a premium on prompt filing, accurate exposure documentation, and benefit structures that account for rapid disease progression.
The rising burden among women and the growth of nonoccupational exposure pathways present the hardest emerging question. Some of these claimants will have exposure histories that do not map onto traditional occupational categories, complicating both compensability and causation. Practitioners, adjusters, and tribunals will increasingly need to evaluate take-home, environmental, and product-based exposures with the same rigor that has long been applied to direct workplace exposures. The study's call for heightened clinical awareness of nontraditional exposure histories applies equally to the compensation system tasked with adjudicating these claims.
The Bottom Line
Mesothelioma in the United States is declining but far from eliminated. It remains overwhelmingly attributable to asbestos, geographically uneven, and highly lethal, with no meaningful improvement in survival despite decades of regulation. For the workers' compensation community, the message is clear: legacy asbestos will continue to generate claims for many years, the occupational link remains strong enough to support compensability, and the rising burden among women demands attention to exposure pathways that fall outside the traditional occupational frame. Vigilance, not complacency, is the appropriate response to falling rates.
Sources
1. Edwards K, Jani CT, Rowley K, et al. Geographic, Temporal, and Sex-Specific Trends in Mesothelioma Burden in the United States, 1990-2023. JCO Global Oncology 12:e2600056, 2026. https://doi.org/10.1200/GO-26-00056
2. Borel v. Fibreboard Paper Products Corp., 493 F.2d 1076 (5th Cir. 1973), cert. denied, 419 U.S. 869 (1974). CourtListener. https://www.courtlistener.com/opinion/317822/clarence-borel-v-fibreboard-paper-products-corporation-nationalsurety/
3. Global Burden of Disease Study 2023 (GBD 2023) Results. Institute for Health Metrics and Evaluation (IHME). https://vizhub.healthdata.org/gbd-results/
4. Mazurek JM, Blackley DJ, Weissman DN. Malignant mesothelioma mortality in women, United States, 1999-2020. MMWR Morb Mortal Wkly Rep 71:645-649, 2022.
5. US EPA. Final Risk Evaluation for Asbestos, Part 1: Chrysotile Asbestos, 2020.https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/final-risk-evaluation-asbestos-part-1-chrysotile
Jon L. Gelman of Wayne, NJ is the author of NJ Workers' Compensation Law (West-Thomson-Reuters) and co-author of Modern Workers' Compensation Law (West-Thomson-Reuters).
Blog: Workers' Compensation | LinkedIn: JonGelman | Substack: jongelman.substack.com | Blue Sky: jongelman@bsky.social
© 2026 Jon L Gelman. All rights reserved. | Attorney Advertising |
Prior results do not guarantee a similar outcome.
No comments:
Post a Comment